These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

392 related items for PubMed ID: 15661808

  • 1. Involvement of transcription factor Sp1 in quercetin-mediated inhibitory effect on the androgen receptor in human prostate cancer cells.
    Yuan H, Gong A, Young CY.
    Carcinogenesis; 2005 Apr; 26(4):793-801. PubMed ID: 15661808
    [Abstract] [Full Text] [Related]

  • 2. Tea polyphenols down-regulate the expression of the androgen receptor in LNCaP prostate cancer cells.
    Ren F, Zhang S, Mitchell SH, Butler R, Young CY.
    Oncogene; 2000 Apr 06; 19(15):1924-32. PubMed ID: 10773882
    [Abstract] [Full Text] [Related]

  • 3. Novel steroid receptor phyto-modulator compound a inhibits growth and survival of prostate cancer cells.
    Yemelyanov A, Czwornog J, Gera L, Joshi S, Chatterton RT, Budunova I.
    Cancer Res; 2008 Jun 15; 68(12):4763-73. PubMed ID: 18559523
    [Abstract] [Full Text] [Related]

  • 4. TR2 orphan receptor functions as negative modulator for androgen receptor in prostate cancer cells PC-3.
    Mu X, Chang C.
    Prostate; 2003 Oct 01; 57(2):129-33. PubMed ID: 12949936
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Regulation of FGF8 expression by the androgen receptor in human prostate cancer.
    Gnanapragasam VJ, Robson CN, Neal DE, Leung HY.
    Oncogene; 2002 Aug 01; 21(33):5069-80. PubMed ID: 12140757
    [Abstract] [Full Text] [Related]

  • 9. TGF-beta signaling and androgen receptor status determine apoptotic cross-talk in human prostate cancer cells.
    Zhu ML, Partin JV, Bruckheimer EM, Strup SE, Kyprianou N.
    Prostate; 2008 Feb 15; 68(3):287-95. PubMed ID: 18163430
    [Abstract] [Full Text] [Related]

  • 10. Peroxisome proliferator-activated receptor gamma-independent suppression of androgen receptor expression by troglitazone mechanism and pharmacologic exploitation.
    Yang CC, Wang YC, Wei S, Lin LF, Chen CS, Lee CC, Lin CC, Chen CS.
    Cancer Res; 2007 Apr 01; 67(7):3229-38. PubMed ID: 17409431
    [Abstract] [Full Text] [Related]

  • 11. Synergistic activation of the androgen receptor by bombesin and low-dose androgen.
    Dai J, Shen R, Sumitomo M, Stahl R, Navarro D, Gershengorn MC, Nanus DM.
    Clin Cancer Res; 2002 Jul 01; 8(7):2399-405. PubMed ID: 12114445
    [Abstract] [Full Text] [Related]

  • 12. FOXP1 is an androgen-responsive transcription factor that negatively regulates androgen receptor signaling in prostate cancer cells.
    Takayama K, Horie-Inoue K, Ikeda K, Urano T, Murakami K, Hayashizaki Y, Ouchi Y, Inoue S.
    Biochem Biophys Res Commun; 2008 Sep 19; 374(2):388-93. PubMed ID: 18640093
    [Abstract] [Full Text] [Related]

  • 13. Sp1 and Sp3 transcription factors upregulate the proximal promoter of the human prostate-specific antigen gene in prostate cancer cells.
    Shin T, Sumiyoshi H, Matsuo N, Satoh F, Nomura Y, Mimata H, Yoshioka H.
    Arch Biochem Biophys; 2005 Mar 15; 435(2):291-302. PubMed ID: 15708372
    [Abstract] [Full Text] [Related]

  • 14. DNA methylation in the androgen receptor gene promoter region in rat prostate cancers.
    Takahashi S, Inaguma S, Sakakibara M, Cho YM, Suzuki S, Ikeda Y, Cui L, Shirai T.
    Prostate; 2002 Jun 01; 52(1):82-8. PubMed ID: 11992622
    [Abstract] [Full Text] [Related]

  • 15. Activation of p300 histone acetyltransferase activity and acetylation of the androgen receptor by bombesin in prostate cancer cells.
    Gong J, Zhu J, Goodman OB, Pestell RG, Schlegel PN, Nanus DM, Shen R.
    Oncogene; 2006 Mar 30; 25(14):2011-21. PubMed ID: 16434977
    [Abstract] [Full Text] [Related]

  • 16. Inhibitory effect of acetyl-11-keto-beta-boswellic acid on androgen receptor by interference of Sp1 binding activity in prostate cancer cells.
    Yuan HQ, Kong F, Wang XL, Young CY, Hu XY, Lou HX.
    Biochem Pharmacol; 2008 Jun 01; 75(11):2112-21. PubMed ID: 18430409
    [Abstract] [Full Text] [Related]

  • 17. Suppression of androgen receptor expression by dibenzoylmethane as a therapeutic objective in advanced prostate cancer.
    Jackson KM, Frazier MC, Harris WB.
    Anticancer Res; 2007 Jun 01; 27(3B):1483-8. PubMed ID: 17595765
    [Abstract] [Full Text] [Related]

  • 18. Androgen receptor-dependent regulation of Bcl-xL expression: Implication in prostate cancer progression.
    Sun A, Tang J, Hong Y, Song J, Terranova PF, Thrasher JB, Svojanovsky S, Wang HG, Li B.
    Prostate; 2008 Mar 01; 68(4):453-61. PubMed ID: 18196538
    [Abstract] [Full Text] [Related]

  • 19. [The roles of c-Jun and CBP in the inhibitory effect of quercetin on prostate cancer cells].
    Yuan HQ, Guo HF, He ML, Kong F, Hu XY, Jiang AL, Xu X, Zhang JY, Charles YF.
    Yao Xue Xue Bao; 2006 Sep 01; 41(9):819-24. PubMed ID: 17111826
    [Abstract] [Full Text] [Related]

  • 20. PC3, but not DU145, human prostate cancer cells retain the coregulators required for tumor suppressor ability of androgen receptor.
    Litvinov IV, Antony L, Dalrymple SL, Becker R, Cheng L, Isaacs JT.
    Prostate; 2006 Sep 01; 66(12):1329-38. PubMed ID: 16835890
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 20.